813 Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro

Bibliographic Details
Title: 813 Combination of HexaBody-CD27 with PD-(L)1 blockade potentiates single-agent activity leading to enhanced human T-cell effector functions in vitro
Authors: Jordan Blum, Alexander Muik, Isil Altintas, Friederike Gieseke, Aras Toker, Esther Breij, Tahamtan Ahmadi, Ugur Sahin, Kristel Kemper, Oezlem Tuereci, Kristina Nuermberger, Sina Fellermeier-Kopf, Andrea Imle, Anna-Lena Krause, Lidia Daszkiewicz
Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Publisher Information: BMJ Publishing Group, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2023-SITC2023.0813
Access URL: https://doaj.org/article/5b2dfbe7a11a49c1a72650313cf5a53d
Accession Number: edsdoj.5b2dfbe7a11a49c1a72650313cf5a53d
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2023-SITC2023.0813
Published in:Journal for ImmunoTherapy of Cancer
Language:English